Literature DB >> 12207322

On cross-priming of MHC class I-specific CTL: rule or exception?

Rolf M Zinkernagel1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12207322     DOI： 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN： 0014-2980            Impact factor:   5.532


× No keyword cloud information.
  36 in total

1.  Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming.

Authors:  Stefan Freigang; Denise Egger; Kurt Bienz; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

2.  Monocytes, viruses and metaphors: hanging the Trojan horse.

Authors:  Jonathan W Yewdell; Christopher B Brooke
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

Review 3.  Tolerance: an overview and perspectives.

Authors:  Herman Waldmann
Journal:  Nat Rev Nephrol       Date:  2010-08-17       Impact factor: 28.314

Review 4.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

5.  Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies.

Authors:  Christiane Ruedl; Katrin Schwarz; Andrea Jegerlehner; Tazio Storni; Vania Manolova; Martin F Bachmann
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 6.  Pathways for antigen cross presentation.

Authors:  Pierre Guermonprez; Sebastian Amigorena
Journal:  Springer Semin Immunopathol       Date:  2004-12-03

7.  The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture.

Authors:  Petra Schnorrer; Georg M N Behrens; Nicholas S Wilson; Joanne L Pooley; Christopher M Smith; Dima El-Sukkari; Gayle Davey; Fiona Kupresanin; Ming Li; Eugene Maraskovsky; Gabrielle T Belz; Francis R Carbone; Ken Shortman; William R Heath; Jose A Villadangos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-28       Impact factor: 11.205

8.  Immunogenicity of cytopathic and noncytopathic viral vectors.

Authors:  Gabriela Plesa; Philip M McKenna; Matthias J Schnell; Laurence C Eisenlohr
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

9.  Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response.

Authors:  Ren-Huan Xu; Sanda Remakus; Xueying Ma; Felicia Roscoe; Luis J Sigal
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

Review 10.  How do regulatory T cells work?

Authors:  A Corthay
Journal:  Scand J Immunol       Date:  2009-10       Impact factor: 3.487
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.